Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 128.50 127.00 130.00 128.50 128.50 128.50 57,737 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 13.0 -23.1 -8.4 - 199

Amryt Pharma PLC Holding(s) in Company

23/12/2019 11:22am

UK Regulatory (RNS & others)


TIDMAMYT

RNS Number : 8379X

Amryt Pharma PLC

23 December 2019

TR-1: Standard form for notification of major holdings

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible)(i) 
 
 1a. Identity of the issuer or the                                         Amryt Pharma plc 
  underlying issuer of existing shares 
  to which voting rights are attached(ii) 
  : 
                                                             -------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                     ---- 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                           X 
                                                                                                     ---- 
 An acquisition or disposal of financial instruments 
                                                                                                     ---- 
 An event changing the breakdown of voting rights 
                                                                                                     ---- 
 Other (please specify)(iii) : 
                                                                                                     ---- 
 3. Details of person subject to the notification obligation(iv) 
 Name                                                                   Highbridge Capital Management LLC 
 City and country of registered office                                            New York, United States 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.)(v) 
 Name 
                                                             -------------------------------------------- 
 City and country of registered office 
  (if applicable) 
                                                             -------------------------------------------- 
 5. Date on which the threshold was                                                      19 December 2019 
  crossed or reached(vi) : 
                                                             -------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):                                          20 December 2019 
                                                             -------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                              % of voting       % of voting rights    Total of both   Total number 
                            rights attached      through financial     in % (8.A +     of voting rights 
                            to shares (total        instruments            8.B)        of issuer(vii) 
                                of 8. A)           (total of 8.B 
                                                    1 + 8.B 2) 
                          ------------------  ---------------------  --------------  -------------------- 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached                     4.44%                2.81%               7.25%           152,853,782 
                          ------------------  ---------------------  --------------  -------------------- 
 Position of 
  previous notification 
  (if 
  applicable)                    5.03%                2.81%               7.84% 
                          ------------------  ---------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on which the 
  threshold was crossed or reached(viii) 
 A: Voting rights attached to shares 
 Class/type of        Number of voting rights(ix)                           % of voting rights 
  shares 
  ISIN code (if 
  possible) 
                               Direct                    Indirect                 Direct                Indirect 
                         (Art 9 of Directive        (Art 10 of Directive    (Art 9 of Directive   (Art 10 of Directive 
                             2004/109/EC)               2004/109/EC)           2004/109/EC)           2004/109/EC) 
                               (DTR5.1)                  (DTR5.2.1)              (DTR5.1)              (DTR5.2.1) 
                                                 ------------------------ 
    GB00BKLTQ412                                         6,784,650                                       4.43% 
                     --------------------------  ------------------------  --------------------  --------------------- 
 
 
 SUBTOTAL 8. A                             6,784,650                                          4.44% 
                     ----------------------------------------------------  ------------------------------------------- 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of financial    Expiration        Exercise/                      Number of voting           % of voting 
  instrument           date(x)           Conversion Period(xi)          rights that may            rights 
                                                                        be acquired if 
                                                                        the instrument 
                                                                        is 
                                                                        exercised/converted. 
                     ----------------  -----------------------------  -------------------------  --------------------- 
      American 
     Depository 
       Receipt              n/a                     n/a                       4,289,175                  2.81% 
                     ----------------  -----------------------------  -------------------------  --------------------- 
 
 
                                        SUBTOTAL 8. B 
                                         1                                    4,289,175                  2.81% 
                                       -----------------------------  -------------------------  --------------------- 
 
 
 
 
 B 2: Financial Instruments with similar economic effect according to 
  Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of financial   Expiration    Exercise/       Physical or        Number of      % of voting 
     instrument        date(x)     Conversion          cash          voting rights      rights 
                                   Period (xi)    settlement(xii) 
                    -----------  -------------  -----------------  --------------- 
 
 
 
                                                  SUBTOTAL 8.B.2 
                                                -----------------  --------------- 
 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer(xiii) 
 Full chain of controlled undertakings through which the voting rights                              X 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity(xiv) (please add additional 
  rows as necessary) 
          Name(xv)              % of voting rights      % of voting rights        Total of both if 
                                  if it equals or        through financial         it equals or is 
                                is higher than the       instruments if it         higher than the 
                               notifiable threshold     equals or is higher      notifiable threshold 
                                                        than the notifiable 
                                                             threshold 
                             -----------------------  ----------------------  ------------------------ 
 JPMorgan Asset Management 
  Holdings Inc. 
                             -----------------------  ----------------------  ------------------------ 
 Highbridge Capital 
  Management, LLC                                                                       7.25% 
                                                                              ------------------------ 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder                                                                          N/A 
                                                      ------------------------------------------------ 
 The number and % of voting rights                                                                 N/A 
  held 
                                                      ------------------------------------------------ 
 The date until which the voting rights                                                            N/A 
  will be held 
                                                      ------------------------------------------------ 
 
 11. Additional information(xvi) 
 
   Chain of controlled undertakings: 
 
   JPMorgan Asset Management Holdings Inc. 
   Highbridge Capital Management, LLC 
 
 
 
 Place of completion   London, United Kingdom 
 Date of completion          20 December 2019 
                      ----------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLZMMZZMFGGLZM

(END) Dow Jones Newswires

December 23, 2019 06:22 ET (11:22 GMT)

1 Year Amryt Pharma Chart

1 Year Amryt Pharma Chart

1 Month Amryt Pharma Chart

1 Month Amryt Pharma Chart
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200221 16:19:49